Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Jost

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Pharmacology|May 10, 2011
Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparationsTamás Szél, István Koncz, Norbert Jost, et al.
Pflugers Archiv : European Journal of Physiology|June 29, 2013
[Ca²⁺] i-induced augmentation of the inward rectifier potassium current (IK1) in canine and human ventricular myocardiumNorbert Nagy, Károly Acsai, Anita Kormos, et al.
Elife|April 10, 2024
Neural network emulation of the human ventricular cardiomyocyte action potential for more efficient computations in pharmacological studiesThomas Grandits, Christoph M Augustin, Gundolf Haase, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 19, 2018
Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action PotentialPéter Orvos, Zsófia Kohajda, Jozefina Szlovák, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
Neural network emulation of the human ventricular cardiomyocyte action potential: a tool for more efficient computation in pharmacological studiesThomas Grandits, Christoph M Augustin, Gundolf Haase, et al.
Circulation|September 1, 2005
Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscleNorbert Jost, László Virág, Miklós Bitay, et al.
Canadian Journal of Physiology and Pharmacology|July 30, 2013
L-364,373 (R-L3) enantiomers have opposite modulating effects on IKs in mammalian ventricular myocytesClaudia Corici, Zsófia Kohajda, Attila Kristóf, et al.
Plos One|January 10, 2013
Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserveAttila Kristóf, Zoltán Husti, István Koncz, et al.
Canadian Journal of Physiology and Pharmacology|September 24, 2020
Antiarrhythmic and cardiac electrophysiological effects of SZV-270, a novel compound with combined Class I/B and Class III effects, in rabbits and dogsRichárd S Varga, Tibor Hornyik, Zoltán Husti, et al.
Canadian Journal of Physiology and Pharmacology|April 20, 2022
Species-dependent differences in the inhibition of various potassium currents and in their effects on repolarization in cardiac ventricular muscleTamás Árpádffy-Lovas, Aiman Saleh A Mohammed, Muhammad Naveed, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Pharmacology|May 10, 2011
Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparationsTamás Szél, István Koncz, Norbert Jost, et al.
Pflugers Archiv : European Journal of Physiology|June 29, 2013
[Ca²⁺] i-induced augmentation of the inward rectifier potassium current (IK1) in canine and human ventricular myocardiumNorbert Nagy, Károly Acsai, Anita Kormos, et al.
Elife|April 10, 2024
Neural network emulation of the human ventricular cardiomyocyte action potential for more efficient computations in pharmacological studiesThomas Grandits, Christoph M Augustin, Gundolf Haase, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 19, 2018
Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action PotentialPéter Orvos, Zsófia Kohajda, Jozefina Szlovák, et al.
Biorxiv : the Preprint Server for Biology|January 18, 2024
Neural network emulation of the human ventricular cardiomyocyte action potential: a tool for more efficient computation in pharmacological studiesThomas Grandits, Christoph M Augustin, Gundolf Haase, et al.
Circulation|September 1, 2005
Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscleNorbert Jost, László Virág, Miklós Bitay, et al.
Canadian Journal of Physiology and Pharmacology|July 30, 2013
L-364,373 (R-L3) enantiomers have opposite modulating effects on IKs in mammalian ventricular myocytesClaudia Corici, Zsófia Kohajda, Attila Kristóf, et al.
Plos One|January 10, 2013
Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserveAttila Kristóf, Zoltán Husti, István Koncz, et al.
Canadian Journal of Physiology and Pharmacology|September 24, 2020
Antiarrhythmic and cardiac electrophysiological effects of SZV-270, a novel compound with combined Class I/B and Class III effects, in rabbits and dogsRichárd S Varga, Tibor Hornyik, Zoltán Husti, et al.
Canadian Journal of Physiology and Pharmacology|April 20, 2022
Species-dependent differences in the inhibition of various potassium currents and in their effects on repolarization in cardiac ventricular muscleTamás Árpádffy-Lovas, Aiman Saleh A Mohammed, Muhammad Naveed, et al.
Pageof 6